The efficacy of ferric citrate hydrate in chronic kidney disease with mild hyperphosphatemia: randomized controlled open-labeled trial
Not Applicable
- Conditions
- predialysis chronic kidney disease (predialysis CKD)
- Registration Number
- JPRN-UMIN000018118
- Lead Sponsor
- Osaka Medical College, department of Internal Medicine 3
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1)impossible dose of ferric citrate hydrate 2)already medicated by other phsphate binders 3)patients participating in other clinical intervention trial 4)presence of severe complication 5)Physician's decision
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method global outcome as both kidney outcome and CVD events.
- Secondary Outcome Measures
Name Time Method renal dysfunction rate, onset of CVD, bone fracture, the frequency of infection, effects of anemia, effects of CKD-MBD, effects of medication